SLC5A7 and thanatophoric dysplasia: Results indicated that TD decreased the bone quality and changed gene expression of tibial growth plates (COL1A1, COL5A1, and COL8A1) and blood (EPSTI1, USP41, and SLC5A7), which could help uncover the underlying mechanisms and identify practical molecular markers for TD.